Previous Close | 966.30 |
Open | 970.38 |
Bid | 962.09 x 200 |
Ask | 962.99 x 200 |
Day's Range | 959.25 - 970.79 |
52 Week Range | 684.81 - 998.33 |
Volume | |
Avg. Volume | 503,318 |
Market Cap | 106.161B |
Beta (5Y Monthly) | 0.11 |
PE Ratio (TTM) | 27.79 |
EPS (TTM) | 34.64 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1,041.59 |
Subscribe to Yahoo Finance Plus to view Fair Value for REGN
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.
Shares of Eli Lilly and Regeneron are both well into the range where splits would make sense.
With Zola Therapeutics, Krieg plans to design and sell a series of cancer immunotherapies without the help of outside investors, he told BioPharma Dive.